JP2013526620A5 - - Google Patents

Download PDF

Info

Publication number
JP2013526620A5
JP2013526620A5 JP2013509410A JP2013509410A JP2013526620A5 JP 2013526620 A5 JP2013526620 A5 JP 2013526620A5 JP 2013509410 A JP2013509410 A JP 2013509410A JP 2013509410 A JP2013509410 A JP 2013509410A JP 2013526620 A5 JP2013526620 A5 JP 2013526620A5
Authority
JP
Japan
Prior art keywords
glycosaminoglycan
lipid moiety
modified
composition according
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013509410A
Other languages
English (en)
Japanese (ja)
Other versions
JP6120283B2 (ja
JP2013526620A (ja
Filing date
Publication date
Priority claimed from CA2703532A external-priority patent/CA2703532C/en
Application filed filed Critical
Publication of JP2013526620A publication Critical patent/JP2013526620A/ja
Publication of JP2013526620A5 publication Critical patent/JP2013526620A5/ja
Application granted granted Critical
Publication of JP6120283B2 publication Critical patent/JP6120283B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013509410A 2010-05-10 2011-05-04 化粧及び薬剤用途に適した局所投与用、皮膚浸透性グリコサミノグリカン調剤 Expired - Fee Related JP6120283B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,703,532 2010-05-10
CA2703532A CA2703532C (en) 2010-05-10 2010-05-10 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
PCT/CA2011/000512 WO2011140630A1 (en) 2010-05-10 2011-05-04 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications

Publications (3)

Publication Number Publication Date
JP2013526620A JP2013526620A (ja) 2013-06-24
JP2013526620A5 true JP2013526620A5 (cg-RX-API-DMAC7.html) 2014-06-19
JP6120283B2 JP6120283B2 (ja) 2017-04-26

Family

ID=44912981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509410A Expired - Fee Related JP6120283B2 (ja) 2010-05-10 2011-05-04 化粧及び薬剤用途に適した局所投与用、皮膚浸透性グリコサミノグリカン調剤

Country Status (10)

Country Link
US (2) US20130059769A1 (cg-RX-API-DMAC7.html)
EP (1) EP2569364B1 (cg-RX-API-DMAC7.html)
JP (1) JP6120283B2 (cg-RX-API-DMAC7.html)
KR (1) KR101831215B1 (cg-RX-API-DMAC7.html)
CN (2) CN107814853A (cg-RX-API-DMAC7.html)
AU (1) AU2011252695B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012028592A2 (cg-RX-API-DMAC7.html)
CA (1) CA2703532C (cg-RX-API-DMAC7.html)
RU (1) RU2637443C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011140630A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014001148A (ja) * 2012-06-15 2014-01-09 Picaso Cosmetic Laboratory Ltd 線維芽細胞増殖促進剤
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
EP2981283A4 (en) * 2013-04-03 2017-07-05 Cedars-Sinai Medical Center Treatment of inflammatory conditions by modulation of hyaluronan and hyaluronidase activity
CA3020400A1 (en) * 2016-04-12 2017-10-19 Illustris Pharmaceuticals, Inc. Compositions for topical application of compounds
KR102955766B1 (ko) 2018-05-03 2026-04-22 콜플랜트 리미티드 진피 충전제 및 이의 적용
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
CN110339223A (zh) * 2019-08-06 2019-10-18 无锡市新吴区新安街道社区卫生服务中心 一种缓解颈椎病症状的喷雾剂制备方法
US20210106506A1 (en) * 2019-10-11 2021-04-15 Elc Management Llc Methods for cosmetic skin remodeling
CN110755597B (zh) * 2019-10-24 2023-07-07 广州市希丽生物科技服务有限公司 用于预防和治疗类风湿性关节炎的外用药物组合物
CN111249472B (zh) * 2020-01-16 2024-02-23 上海交通大学医学院附属第九人民医院 一种可经皮给药的透明质酸纳米凝胶及其制备方法
CN111166692A (zh) * 2020-03-18 2020-05-19 深圳市百吉因生物科技有限公司 一种高保湿性组合物
KR102583416B1 (ko) * 2020-04-14 2023-10-04 코스맥스 주식회사 저분자 콜라겐, 엘라스틴 및 글리코사미노글리칸을 포함하는 화장료 조성물
WO2022163336A1 (ja) 2021-01-29 2022-08-04 株式会社コーセー セラミド類含有組成物
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
CN117137830B (zh) * 2023-11-01 2024-02-13 杭州湃肽生化科技有限公司 一种皮肤修复组合物及其应用
CN120168654A (zh) * 2025-05-21 2025-06-20 长春赛诺美焱科技有限公司 一种透皮递送耦合物、缓释透皮制剂及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009282A (en) * 1973-12-17 1977-02-22 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with prostaglandins
US5464942A (en) * 1990-07-24 1995-11-07 Seikagaku Kogyo Kabushiki Kaisha Phospholipid- or lipid-linked glycosaminoglycan and process for producing the same
JP2997018B2 (ja) * 1990-07-24 2000-01-11 生化学工業株式会社 燐脂質又は脂質結合グリコサミノグリカン
US5733892A (en) * 1990-07-24 1998-03-31 Seikagaku Corporation Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same
JP3714683B2 (ja) * 1992-07-30 2005-11-09 生化学工業株式会社 抗リウマチ剤
JP3615346B2 (ja) * 1997-02-18 2005-02-02 株式会社ノエビア 皮膚外用剤
JP3032824B1 (ja) * 1999-01-28 2000-04-17 東京医科歯科大学長 骨誘導促進剤
US7504384B2 (en) * 2000-01-10 2009-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of infection
US7393938B2 (en) * 2000-01-10 2008-07-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
JP4876334B2 (ja) * 2001-06-06 2012-02-15 日油株式会社 ヒアルロン酸産生能増強剤およびその用途
CN100542612C (zh) * 2001-08-14 2009-09-23 特拉维夫大学未来技术研发有限公司 类脂化糖胺聚糖颗粒及其在诊断和治疗用药物和基因传递中的应用
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
CA2513143A1 (en) * 2002-07-01 2004-01-08 Tufts University Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
ES2406555T3 (es) * 2003-10-29 2013-06-07 Teijin Limited Compuesto de ácido hialurónico, hidrogel del mismo y material para tratar articulaciones
US8178129B2 (en) * 2004-11-02 2012-05-15 Tel-Aviv University Future Technology Development L.P. Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
JP4832007B2 (ja) 2005-06-13 2011-12-07 帝人株式会社 グリコサミノグリカン誘導体の製造法
CN1742623A (zh) * 2005-07-13 2006-03-08 凌沛学 透明质酸磷脂复合物及其制备方法
US20080306022A1 (en) * 2005-10-12 2008-12-11 Kenji Miyamoto Agent for Applying to Mucosa and Method for the Production Thereof
US20080183282A1 (en) 2006-03-09 2008-07-31 Saul Yedgar Use of lipid conjugates for the coating of stents and catheters
DE102007028360B4 (de) * 2007-06-15 2016-04-14 Marcus Asam Wirkstoffkombination für kosmetische Zubereitungen
US20090169615A1 (en) * 2007-12-26 2009-07-02 Pinsky Mark A Collagen Formulations for Improved Skin Care
WO2009108554A2 (en) * 2008-02-27 2009-09-03 Ramot At Tel Aviv University Ltd. System for delivery of protein in insoluble fibrillar or aggregate form

Similar Documents

Publication Publication Date Title
RU2012152562A (ru) Проникающие через кожу композиции на основе гликозаминогликана для местного применения в косметических и фармацевтических целях
Morales et al. Novel strategies for the buccal delivery of macromolecules
AU2003246461B9 (en) Carrier
ES2794048T3 (es) Composición que comprende un agente gelificante más glucano
JP2019513799A (ja) 化合物の局所適用を目的とした組成物
CN105491982A (zh) 用于增强透皮递送的肽
JP5932825B2 (ja) グルカンゲル
WO2020043185A1 (zh) 氨基酸类营养素的应用以及包含它的药物组合物
CN103505736A (zh) 基于改性透明质酸的高分子脂质体及其制备方法
WO2012146110A1 (zh) 胰岛素传递体透皮给药制剂及其制备方法
Su et al. Topical adhesive spatio-temporal nanosystem co-delivering chlorin e6 and HMGB1 inhibitor glycyrrhizic acid for in situ psoriasis chemo-phototherapy
CY1121145T1 (el) Συστημα χορηγησης φαρμακων για χορηγηση μιας υδατοδιαλυτης, κατιοντικης και αμφιφιλης φαρμακευτικως ενεργης ουσιας
CA2616449C (en) Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
KR20240042000A (ko) 분리된 다당류 화합물 및 사용 및 제조의 방법
JP2016513686A (ja) フルチカゾンの経皮製剤
JP2021535170A (ja) 薬物送達のための相乗的な透過促進剤を伴う組成物
ITUB20154846A1 (it) Composizione orale in forma di gel comprendente chitosano, pectina ad alto grado di metossilazione, una sostanza zuccherina, L-carnitina ed N-acetilcisteina
FI3954360T3 (fi) Hiilihydraattien lääkevalmiste terapeuttiseen käyttöön
WO2014209246A1 (en) Design of terbinafine hydrochloride loaded liposome included pullulan film system for ungual treatment of onychomycosis
CN108126209A (zh) 一种时序释放姜黄素和化疗药物的纳米递药系统及其应用
EP2440179A2 (de) Zusammensetzungen auf basis von chitosan-oligosacchariden
WO2003054208A2 (en) Method of modulating release of saccharides and uses thereof
KR20170113913A (ko) 메칠설포닐메탄 및 글루코사민이 포집된 나노리포좀을 포함하는 국소도포 제제 조성물
WO2011000889A1 (en) Topical vaccine formulations and methods of treating drug addiction using same
CN1651397A (zh) 一种含有脂肪酸的薄荷醇衍生物及含有该衍生物的制剂